Mark C. Pigott, the Executive Chairman of PACCAR Inc, has reported a transaction involving the sale of shares from his PACCAR Savings Investment Plan. This event is significant as it showcases the ongoing changes in executive ownership within the company and emphasizes transparency in the motor vehicle industry.
According to the recent SEC filing dated November 6, 2026, Pigott sold 0.434 shares at a price of $106.13 on November 4, 2026. Following this transaction, he retains a direct ownership of over 5.2 million shares of PACCAR Inc, while his wife and children hold approximately 424,920 shares.
Background
PACCAR Inc, a leader in the manufacturing of motor vehicles and passenger car bodies, is headquartered in Bellevue, Washington. The company has a rich history and is known for its commitment to innovation and quality in the automotive sector. The filing history shows a pattern of regular reporting by Pigott, indicating his active engagement in the company’s governance.
What the Filing Says
The SEC filing, accession number 0001225208-26-008740, indicates that the transaction was a sale of fractional interest related to a transfer from the PACCAR Savings Investment Plan to Pigott's direct registration account. It states, "Sale of fractional interest relating to transfer from PACCAR Savings and Investment Plan (SIP) to direct registration account." This highlights the structured approach PACCAR takes towards executive transactions.
Impact
This transaction may affect PACCAR's stakeholders, including shareholders and employees, as it reflects the executive's ongoing commitment to the company while also ensuring compliance with regulatory requirements. The clarity in reporting these transactions fosters trust among investors and reinforces PACCAR's reputation in the industry.
What's Next
The filing does not say what happens next.
Read Next
Russell Investments Group reveals $114B in latest 13F-HR
FB Financial Corp's Beth Sims Transfers Shares in Strategic Move
Russell Investments Japan files 13F-NT for Q3 2026
Perspective Therapeutics reveals interim trial results for VMT01
American Century Files Certification for Prospectus Update
FS Bancorp's Crowl Acquires Shares in Recent Transactions










